Mapletree Industrial Trust to buy US data centre for up to US$262.1m

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

MAPLETREE Industrial Trust (MIT) is proposing to acquire a data centre and office in the US state of Virginia for between US$200.6 million and US$262.1 million, subject to the calibration of terms. Read more at The Business Times.

Including other fees and expenses, the total acquisition outlay for MIT is estimated to be between US$204.3 million and US$266.9 million. The manager intends to fund this using debt financing, proceeds from an equity fundraising and/or internal cash resources.

The manager said the proposed acquisition is in line with its long-term strategy of focusing on property segments with"future growth potential". The deal will also increase the Reit's exposure to data centres - a resilient asset class with growth opportunities - while increasing its exposure to the US, said to be the world's largest data-centre market, according to the MIT manager.

Among other things, the proposed acquisition is expected to provide income stability and will be accretive to its distribution per unit based on pro forma historical impact. "Due to confidentiality reason, additional details relating to the proposed acquisition will be released in due course upon finalisation of the purchase consideration," the manager noted.BT is now on Telegram!

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead nears deal to buy Immunomedics for more than US$20 bln -WSJGilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than US$20 billion, the Wall Street Journal ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Gilead nears deal to buy Immunomedics for more than US$20 billion: ReportGilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for US$21 billion in a deal that would further expand Gilead's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Gilead to buy cancer drugmaker Immunomedics for US$21 billionBENGALURU (REUTERS) - Gilead Sciences will acquire biopharmaceutical company Immunomedics for US$21 billion (S$28.7 billion), a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two companies said in a joint statement on Sunday (Sept 13).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »